We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 8,553 results
  1. Alteration of the immune microenvironment in the axillary metastatic lymph nodes of luminal A breast cancer patients

    Background

    The alteration of the immune microenvironment in the axillary metastatic lymph nodes of luminal A breast cancer patients is still unclear.

    ...
    Min Wu, Shuo Wang, ... Shuzhen Lyu in World Journal of Surgical Oncology
    Article Open access 27 June 2024
  2. Impact of axillary surgery on outcome of clinically node positive breast cancer treated with neoadjuvant chemotherapy

    Purpose

    Axillary Lymph Node Dissection (ALND) is recommended for breast cancer patients who present with clinically node positive disease (cN1)...

    Joseph Dux, Mehran Habibi, ... David Euhus in Breast Cancer Research and Treatment
    Article 02 August 2023
  3. Multi-modality radiomics model predicts axillary lymph node metastasis of breast cancer using MRI and mammography

    Objectives

    We aimed to develop a multi-modality model to predict axillary lymph node (ALN) metastasis by combining clinical predictors with radiomic...

    Qian Wang, Yingyu Lin, ... Genji Bai in European Radiology
    Article 10 February 2024
  4. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?

    Purpose

    Salvage mastectomy is traditionally recommended for patients who developed ipsilateral breast tumor recurrence (IBTR) in light of previous...

    Fei-Lin Qu, Cai-** Lin, ... Zhi-Ming Shao in Breast Cancer Research and Treatment
    Article Open access 30 August 2022
  5. Positive predictive value of axillary lymph node cortical thickness and nodal, clinical, and tumor characteristics in newly diagnosed breast cancer patients

    Purpose

    Axillary lymph nodes (LNs) with cortical thickness > 3 mm have a higher likelihood of malignancy. To examine the positive predictive value...

    Anne-Sophie T. Loonis, Allyson L. Chesebro, ... Catherine S. Giess in Breast Cancer Research and Treatment
    Article 10 November 2023
  6. Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study

    Background

    Several techniques exist for performing targeted axillary dissection (TAD) after neoadjuvant chemotherapy with the removal of the sentinel...

    Frederikke Munck, Pernille Jepsen, ... Tove H. F. Tvedskov in Annals of Surgical Oncology
    Article Open access 03 July 2023
  7. Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy

    Background

    Any advantage of performing targeted axillary dissection (TAD) compared to sentinel lymph node (SLN) biopsy (SLNB) is under debate in...

    Neslihan Cabıoğlu, Hasan Karanlık, ... Memduh Dursun in World Journal of Surgical Oncology
    Article Open access 06 July 2024
  8. Comparison of the effect of ultrasounic-harmonic scalpel and electrocautery in the treatment of axillary lymph nodes during radical surgery for breast cancer

    Objective

    To compare the efficacy of ultrasounic-harmonic scalpel and electrocautery in the treatment of axillary lymph nodes during radical surgery...

    Yujia Tian, Lifei Han, ... Haolin Hu in World Journal of Surgical Oncology
    Article Open access 11 April 2024
  9. Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: a multicenter study

    Objectives

    Develo** a deep learning radiomics model from longitudinal breast ultrasound and sonographer’s axillary ultrasound diagnosis for...

    Ying Fu, Yu-Tao Lei, ... Li-Gang Cui in European Radiology
    Article Open access 10 May 2024
  10. Overuse of Axillary Surgery in Patients with Ductal Carcinoma In Situ: Opportunity for De-escalation

    Background

    Ductal carcinoma in situ (DCIS) is noninvasive breast cancer and therefore nodal staging is not routinely recommended. We evaluated the use...

    Mara A. Piltin, Tanya L. Hoskin, ... Judy C. Boughey in Annals of Surgical Oncology
    Article 05 July 2022
  11. Health-related quality of life (HRQoL) after different axillary treatments in women with breast cancer: a 1-year longitudinal cohort study

    Purpose

    As life expectancy continues to rise, post-treatment health-related quality of life (HRQoL) of breast cancer patients becomes increasingly...

    N. J. M. C. Vrancken Peeters, Z. L. R. Kaplan, ... L. B. Koppert in Quality of Life Research
    Article Open access 27 October 2023
  12. Non-invasive predictors of axillary lymph node burden in breast cancer: a single-institution retrospective analysis

    Purpose

    Axillary staging is an important prognostic factor in breast cancer. Sentinel lymph node biopsy (SNB) is currently used to stage patients who...

    Victoria Ngai, Justina Cheh Juan Tai, ... Muneer Ahmed in Breast Cancer Research and Treatment
    Article Open access 21 July 2022
  13. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study

    Objectives

    To evaluate if radiomics with machine learning can differentiate between F-18-fluorodeoxyglucose (FDG)-avid breast cancer metastatic...

    Michal Eifer, Hodaya Pinian, ... Liran Domachevsky in European Radiology
    Article 06 April 2022
  14. Axillary lymph node metastasis in pure mucinous carcinoma of breast: clinicopathologic and ultrasonographic features

    Background

    The purpose of this research is to study the sonographic and clinicopathologic characteristics that associate with axillary lymph node...

    Na Li, Jia-Wei Li, ... Cai Chang in BMC Medical Imaging
    Article Open access 14 May 2024
  15. Clip** the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial

    Background

    For patients with clinically node-positive (cN+) breast cancer undergoing neoadjuvant chemotherapy (NAC), retrieving previously clipped,...

    Kayla M. Switalla, Judy C. Boughey, ... Rita A. Mukhtar in Annals of Surgical Oncology
    Article Open access 12 July 2024
  16. Omission of Surgical Axillary Lymph Node Staging in Patients with Tubular Breast Cancer

    Background

    With more effective screening and treatment strategies, there is debate over whether surgical axillary staging should be deescalated for...

    Enver Özkurt, Stephanie Wong, ... Thanh U. Barbie in Annals of Surgical Oncology
    Article 19 October 2020
  17. Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor pathological response after neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study

    Purpose

    Tumor-infiltrating lymphocytes (TILs) can predict complete pathological response (pCR) of tumor in the breast but not so well-defined in the...

    Kian Chin, Amalia H. Landén, ... Roger Olofsson Bagge in Breast Cancer Research and Treatment
    Article Open access 04 May 2024
  18. Intraoperative assessment of axillary sentinel lymph nodes by telepathology

    Purpose

    Although axillary dissection is no longer indicated for many breast cancer patients with 1–2 positive axillary sentinel lymph nodes (ASLN),...

    Gulisa Turashvili, Sandra Gjorgova Gjeorgjievski, ... Sunil S. Badve in Breast Cancer Research and Treatment
    Article 09 September 2023
Did you find what you were looking for? Share feedback.